bf/NYSE:WST_icon.jpeg

COM:WESTPHARMA

West Pharmaceutical Services, Inc.

  • Stock

USD

Last Close

320.88

22/11 21:00

Market Cap

23.41B

Beta: -

Volume Today

557.15K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
169.55M
-
179.20M
5.69%
181.30M
1.17%
190.20M
4.91%
207.25M
8.96%
214.85M
3.67%
225.10M
4.77%
278.50M
23.72%
349.85M
25.62%
396.60M
13.36%
424.75M
7.10%
average payables
105.45M
-
105.55M
0.09%
111.45M
5.59%
120.90M
8.48%
130.05M
7.57%
134.25M
3.23%
143.60M
6.96%
184.95M
28.80%
222.65M
20.38%
223.80M
0.52%
228.90M
2.28%
average receivables
180.35M
-
182.35M
1.11%
180.20M
1.18%
190.95M
5.97%
226.85M
18.80%
270.70M
19.33%
303.75M
12.21%
352.30M
15.98%
437.15M
24.08%
498.20M
13.97%
509.70M
2.31%
book value per share
13.02
-
13.50
3.64%
14.22
5.37%
15.25
7.21%
17.32
13.60%
18.89
9.09%
21.26
12.52%
25.09
18.04%
31.39
25.09%
36.09
14.97%
38.26
6.02%
capex per share
-2.24
-
-1.58
29.37%
-1.83
15.60%
-2.32
27.04%
-1.77
23.77%
-1.42
19.95%
-1.71
20.56%
-2.36
38.16%
-3.41
44.32%
-3.83
12.31%
-4.81
25.68%
capex to depreciation
-1.83
-
-1.25
31.89%
-1.46
17.53%
-1.88
28.19%
-1.35
27.92%
-1.00
25.86%
-1.22
21.89%
-1.60
30.77%
-2.07
29.62%
-2.36
13.90%
-2.64
11.73%
capex to operating cash flow
-0.71
-
-0.61
13.26%
-0.62
1.09%
-0.78
25.20%
-0.50
35.96%
-0.36
26.97%
-0.34
5.12%
-0.37
7.23%
-0.43
17.56%
-0.39
9.41%
-0.47
18.60%
capex to revenue
-0.11
-
-0.08
30.73%
-0.09
19.21%
-0.11
19.96%
-0.08
27.47%
-0.06
25.47%
-0.07
12.69%
-0.08
18.24%
-0.09
10.16%
-0.10
10.16%
-0.12
24.48%
cash per share
3.41
-
3.60
5.52%
3.81
5.92%
2.77
27.39%
3.19
15.26%
4.57
43.03%
5.93
29.97%
8.33
40.36%
10.25
23.07%
12.02
17.27%
11.34
5.66%
days of inventory on hand
69.15
-
68.04
1.60%
70.02
2.91%
72.17
3.06%
72.29
0.18%
66.80
7.60%
69.71
4.35%
85.04
21.99%
83.41
1.91%
86.48
3.68%
87.15
0.77%
days payables outstanding
42.22
-
38.65
8.45%
46.32
19.84%
44.18
4.63%
46.39
5.02%
40.61
12.46%
46.37
14.19%
56.40
21.63%
51.19
9.25%
44.91
12.26%
48.60
8.21%
days sales outstanding
49.53
-
45.97
7.20%
47.30
2.90%
48.49
2.52%
57.79
19.18%
61.25
5.98%
63.34
3.41%
65.51
3.41%
63.03
3.77%
64.15
1.78%
63.35
1.25%
debt to assets
0.22
-
0.20
9.81%
0.18
12.70%
0.13
24.30%
0.16
20.74%
0.12
23.41%
0.14
14.21%
0.12
17.11%
0.10
15.80%
0.09
10.46%
0.08
8.20%
debt to equity
0.41
-
0.35
14.61%
0.29
17.23%
0.20
29.76%
0.23
14.39%
0.14
39.98%
0.21
49.04%
0.18
16.10%
0.14
20.69%
0.12
15.00%
0.11
9.42%
dividend yield
0.01
-
0.01
1.78%
0.01
3.07%
0.01
22.95%
0.01
6.86%
0.01
8.38%
0.00
30.24%
0.00
43.33%
0.00
36.26%
0.00
110.98%
0.00
30.42%
earnings yield
0.03
-
0.03
2.38%
0.02
34.52%
0.02
4.74%
0.02
10.51%
0.03
38.19%
0.02
23.92%
0.02
23.89%
0.02
14.70%
0.03
76.43%
0.02
33.12%
enterprise value
3.56B
-
3.86B
8.38%
4.36B
13.05%
6.24B
43.22%
7.25B
16.16%
7.10B
2.06%
11.01B
55.07%
20.65B
87.45%
34.46B
66.89%
16.93B
50.86%
25.97B
53.36%
enterprise value over ebitda
21.91
-
21.19
3.29%
33.90
60.00%
31.73
6.41%
31.69
0.13%
28.76
9.24%
27.54
4.22%
39.92
44.94%
39.23
1.74%
19.81
49.49%
29.66
49.67%
ev to operating cash flow
16.14
-
21.08
30.66%
20.52
2.65%
28.46
38.65%
27.55
3.20%
24.61
10.65%
30.00
21.87%
43.70
45.67%
59.00
35.02%
23.39
60.36%
33.44
42.99%
ev to sales
2.60
-
2.71
4.34%
3.11
14.80%
4.14
32.85%
4.54
9.63%
4.14
8.81%
5.99
44.74%
9.62
60.64%
12.17
26.53%
5.87
51.80%
8.80
50.09%
free cash flow per share
0.93
-
1.00
7.42%
1.12
12.38%
0.67
40.19%
1.79
167.12%
2.49
38.79%
3.25
30.76%
4.03
23.96%
4.44
10.16%
5.91
32.91%
5.50
6.79%
free cash flow yield
0.02
-
0.02
1.01%
0.02
0.65%
0.01
57.54%
0.02
129.65%
0.03
39.70%
0.02
14.73%
0.01
34.22%
0.01
33.46%
0.03
164.87%
0.02
37.70%
graham net net
-4.31
-
2.03
146.99%
2.82
39.21%
3.06
8.59%
4.55
48.68%
6.29
38.14%
0.38
93.93%
1.70
346.40%
4.57
168.52%
7.40
61.80%
6.73
9.02%
graham number
21.74
-
23.33
7.30%
20.61
11.66%
25.92
25.77%
28.19
8.74%
34.50
22.38%
39.53
14.57%
51.43
30.12%
79.26
54.11%
79.96
0.89%
82.36
3.00%
income quality
1.96
-
1.44
26.71%
2.22
54.39%
1.53
31.23%
1.75
14.36%
1.39
20.16%
1.52
8.92%
1.36
10.16%
0.88
35.34%
1.24
40.03%
1.31
5.90%
intangibles to total assets
0.10
-
0.09
7.28%
0.08
6.93%
0.07
12.30%
0.07
5.58%
0.08
14.09%
0.06
25.85%
0.05
13.76%
0.04
20.87%
0.03
13.34%
0.03
7.13%
interest coverage
10.75
-
14
30.17%
10.29
26.51%
28.11
173.27%
35.22
25.26%
38.14
8.31%
63.11
65.45%
59.84
5.18%
104.49
74.61%
92.91
11.08%
75.11
19.16%
interest debt per share
5.58
-
4.93
11.66%
4.32
12.51%
3.21
25.52%
4.14
28.83%
2.74
33.86%
4.51
64.80%
4.50
0.31%
4.47
0.67%
4.38
2.02%
4.22
3.56%
inventory turnover
5.28
-
5.36
1.63%
5.21
2.83%
5.06
2.97%
5.05
0.18%
5.46
8.22%
5.24
4.16%
4.29
18.03%
4.38
1.95%
4.22
3.55%
4.19
0.77%
invested capital
0.41
-
0.35
14.61%
0.29
17.23%
0.20
29.76%
0.23
14.39%
0.14
39.98%
0.21
49.04%
0.18
16.10%
0.14
20.69%
0.12
15.00%
0.11
9.42%
market cap
3.41B
-
3.77B
10.55%
4.34B
14.87%
6.22B
43.41%
7.29B
17.27%
7.24B
0.65%
11.12B
53.56%
20.94B
88.20%
34.89B
66.67%
17.51B
49.82%
26.51B
51.43%
net current asset value
-114.50M
-
322.60M
381.75%
375.50M
16.40%
413.30M
10.07%
546.50M
32.23%
698.30M
27.78%
290.50M
58.40%
434.40M
49.54%
763.60M
75.78%
987.60M
29.33%
987.90M
0.03%
net debt to ebitda
0.88
-
0.45
49.38%
0.18
58.97%
0.13
29.12%
-0.17
230.64%
-0.57
236.62%
-0.27
52.00%
-0.56
104.07%
-0.50
11.15%
-0.67
35.48%
-0.62
7.74%
net income per share
1.61
-
1.79
11.10%
1.33
25.93%
1.96
47.55%
2.04
4.09%
2.80
37.29%
3.27
16.66%
4.68
43.43%
8.90
89.88%
7.88
11.47%
7.88
0.07%
operating cash flow per share
3.17
-
2.58
18.57%
2.95
14.35%
2.99
1.46%
3.56
19.03%
3.91
9.61%
4.96
27.06%
6.39
28.85%
7.85
22.77%
9.73
23.97%
10.31
5.97%
payables turnover
8.65
-
9.44
9.23%
7.88
16.56%
8.26
4.85%
7.87
4.78%
8.99
14.24%
7.87
12.42%
6.47
17.78%
7.13
10.19%
8.13
13.98%
7.51
7.59%
receivables turnover
7.37
-
7.94
7.76%
7.72
2.82%
7.53
2.46%
6.32
16.09%
5.96
5.64%
5.76
3.30%
5.57
3.30%
5.79
3.92%
5.69
1.74%
5.76
1.26%
research and ddevelopement to revenue
0.03
-
0.03
5.25%
0.02
7.17%
0.02
0.10%
0.02
0.27%
0.02
4.03%
0.02
9.90%
0.02
3.33%
0.02
14.64%
0.02
8.67%
0.02
14.43%
return on tangible assets
0.07
-
0.08
12.35%
0.06
26.36%
0.09
46.67%
0.09
3.71%
0.14
62.31%
0.11
22.28%
0.13
19.02%
0.21
59.39%
0.17
19.34%
0.16
4.59%
revenue per share
19.66
-
20.05
1.97%
19.44
3.02%
20.59
5.90%
21.64
5.10%
23.24
7.40%
24.86
6.99%
29.05
16.84%
38.06
31.01%
38.80
1.95%
39.17
0.96%
roe
0.12
-
0.13
7.21%
0.09
29.71%
0.13
37.63%
0.12
8.37%
0.15
25.85%
0.15
3.68%
0.19
21.51%
0.28
51.80%
0.22
22.99%
0.21
5.61%
roic
0.09
-
0.10
9.97%
0.08
25.80%
0.10
38.63%
0.09
11.59%
0.12
35.51%
0.12
4.09%
0.15
23.60%
0.24
59.23%
0.20
16.87%
0.17
13.63%
sales general and administrative to revenue
0.17
-
0.16
6.27%
0.17
3.45%
0.16
4.54%
0.15
4.53%
0.15
0.90%
shareholders equity per share
13.02
-
13.50
3.64%
14.22
5.37%
15.25
7.21%
17.32
13.60%
18.89
9.09%
21.26
12.52%
25.09
18.04%
31.39
25.09%
36.09
14.97%
38.26
6.02%
stock based compensation to revenue
0.02
-
0.01
15.54%
0.02
61.60%
0.01
38.89%
0.01
22.08%
0.01
12.67%
0.01
50.83%
0.02
19.42%
0.01
16.38%
0.01
38.01%
0.01
3.78%
tangible asset value
743.90M
-
1.18B
59.11%
1.25B
6.01%
1.36B
8.54%
1.54B
12.82%
1.27B
17.33%
1.44B
13.03%
1.71B
19.32%
2.20B
28.58%
2.56B
16.20%
2.76B
7.74%
tangible book value per share
10.69
-
16.69
56.19%
17.43
4.39%
18.58
6.61%
20.79
11.91%
17.19
17.33%
19.40
12.88%
23.18
19.48%
29.60
27.72%
34.40
16.20%
36.62
6.46%
working capital
413.80M
-
406.80M
1.69%
359.40M
11.65%
400.90M
11.55%
464M
15.74%
610.70M
31.62%
717.10M
17.42%
870.30M
21.36%
1.15B
31.90%
1.40B
22.01%
1.26B
9.70%

All numbers in USD (except ratios and percentages)